Guido Hartmann
- Molecular Biology top 5%
- Hepatology top 0.5%
- Surgery top 5%
- Oncology top 5%
- Physical and Theoretical Chemistry top 1%
- Co-authors
- Walter BirchmeierK. Michael WeidnerYasushi DaikuharaHirohito TsubouchiMatthew S. SachsChrista FonatschT HishidaHarald Rieder
- Topics
- Liver physiology and pathology (9 papers)Retinal Diseases and Treatments (4 papers)Angiogenesis and VEGF in Cancer (4 papers)
- Partner nations
- SwitzerlandGermanyUnited Kingdom
In The Last Decade
Guido Hartmann
38 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Molecular Biology 1.4k
- Hepatology 1.1k
- Surgery 634
- Oncology 570
- Physical and Theoretical Chemistry 365
Countries citing papers authored by Guido Hartmann
This map shows the geographic impact of Guido Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Hartmann more than expected).
Fields of papers citing papers by Guido Hartmann
This network shows the impact of papers produced by Guido Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Hartmann. The network helps show where Guido Hartmann may publish in the future.
Co-authorship network of co-authors of Guido Hartmann
This figure shows the co-authorship network connecting the top 25 collaborators of Guido Hartmann. A scholar is included among the top collaborators of Guido Hartmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Hartmann. Guido Hartmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 14 | |
| 3 | 7 | |
| 4 | What is the biologically relevant KD for VEGF binding to ranibizumab in the eye? A comparison of in-vivo and in-vitro estimates. | 3 |
| 5 | 241 | |
| 6 | Anti -VEGF/Ang2 bi-specific antibody ameliorates endotoxin-induced uveitis in mice | 4 |
| 7 | Bispecific anti-VEGF/ANG2 antibody exhibits superior efficacy to VEGF monotherapy in a model of spontaneous CNV | 1 |
| 8 | 82 | |
| 9 | 1 | |
| 10 | 12 | |
| 11 | 46 | |
| 12 | 105 | |
| 13 | 99 | |
| 14 | 80 | |
| 15 | 423 | |
| 16 | 1 | |
| 17 | 25 | |
| 18 | 16 | |
| 19 | 86 | |
| 20 | Evidence for the identy of human scatter factor and human hepatocyte growth factor. | 153 |
About Guido Hartmann
Guido Hartmann is a scholar working on Microbiology, Hepatology and Nephrology, having authored 38 papers that have together received 3.4k indexed citations. Recurring topics across this work include Liver physiology and pathology (9 papers), Retinal Diseases and Treatments (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). The work is most often cited by research in Hepatology (1.1k citations), Physical and Theoretical Chemistry (365 citations) and Microbiology (20 citations). Guido Hartmann has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include Walter Birchmeier, K. Michael Weidner, Yasushi Daikuhara, Hirohito Tsubouchi, Matthew S. Sachs, Christa Fonatsch, T Hishida, Harald Rieder, N Arakaki and Wolfgang Haap. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.